Xencor to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 23, 2022

Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company, announced it will provide a corporate update and report financial results for Q4 and full year 2021 after market close on February 23, 2022. Management will host a conference call at 4:30 p.m. ET to discuss the updates. Xencor is developing engineered monoclonal antibodies and cytokines to treat cancer and autoimmune diseases, with 22 candidates currently in clinical development.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases, today announced that it will provide a corporate update and report financial results for the fourth quarter and full year 2021 after the market closes on Wednesday, February 23, 2022.

Xencor management will host a conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to provide a corporate update.

The live call may be accessed by dialing (877) 359-9508 for domestic callers or (224) 357-2393 for international callers and referencing conference ID number 5290676. A live webcast of the conference call will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. The webcast will be archived on the company website for 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220216005946/en/

Charles Liles

cliles@xencor.com

Media Contact

Jason I. Spark

Canale Communications

619-849-6005

jason@canalecomm.com

Source: Xencor, Inc.

FAQ

What date will Xencor release its Q4 2021 financial results?

Xencor will release its Q4 2021 financial results on February 23, 2022.

What is the ticker symbol for Xencor?

The ticker symbol for Xencor is XNCR.

What will Xencor discuss on the conference call?

Xencor will provide a corporate update and discuss its financial results during the conference call.

At what time is Xencor's conference call scheduled?

Xencor's conference call is scheduled for 4:30 p.m. ET on February 23, 2022.

How many candidates is Xencor developing?

Xencor is currently developing 22 candidates in clinical development.